Copyright Reports & Markets. All rights reserved.

Global Polymyxin B for Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Polymyxin B for Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 50,000 Units
    • 1.3.3 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Polymyxin B for Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinics
    • 1.4.4 Other
  • 1.5 Global Polymyxin B for Injection Market Size & Forecast
    • 1.5.1 Global Polymyxin B for Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Polymyxin B for Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Polymyxin B for Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Xellia
    • 2.1.1 Xellia Details
    • 2.1.2 Xellia Major Business
    • 2.1.3 Xellia Polymyxin B for Injection Product and Services
    • 2.1.4 Xellia Polymyxin B for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Xellia Recent Developments/Updates
  • 2.2 Fresenius Kabi
    • 2.2.1 Fresenius Kabi Details
    • 2.2.2 Fresenius Kabi Major Business
    • 2.2.3 Fresenius Kabi Polymyxin B for Injection Product and Services
    • 2.2.4 Fresenius Kabi Polymyxin B for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Fresenius Kabi Recent Developments/Updates
  • 2.3 Shanghai Pharmaceuticals
    • 2.3.1 Shanghai Pharmaceuticals Details
    • 2.3.2 Shanghai Pharmaceuticals Major Business
    • 2.3.3 Shanghai Pharmaceuticals Polymyxin B for Injection Product and Services
    • 2.3.4 Shanghai Pharmaceuticals Polymyxin B for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Shanghai Pharmaceuticals Recent Developments/Updates
  • 2.4 Eugia
    • 2.4.1 Eugia Details
    • 2.4.2 Eugia Major Business
    • 2.4.3 Eugia Polymyxin B for Injection Product and Services
    • 2.4.4 Eugia Polymyxin B for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Eugia Recent Developments/Updates
  • 2.5 Gland Pharma
    • 2.5.1 Gland Pharma Details
    • 2.5.2 Gland Pharma Major Business
    • 2.5.3 Gland Pharma Polymyxin B for Injection Product and Services
    • 2.5.4 Gland Pharma Polymyxin B for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Gland Pharma Recent Developments/Updates
  • 2.6 Soigner Pharma
    • 2.6.1 Soigner Pharma Details
    • 2.6.2 Soigner Pharma Major Business
    • 2.6.3 Soigner Pharma Polymyxin B for Injection Product and Services
    • 2.6.4 Soigner Pharma Polymyxin B for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Soigner Pharma Recent Developments/Updates
  • 2.7 Incepta Pharmaceuticals
    • 2.7.1 Incepta Pharmaceuticals Details
    • 2.7.2 Incepta Pharmaceuticals Major Business
    • 2.7.3 Incepta Pharmaceuticals Polymyxin B for Injection Product and Services
    • 2.7.4 Incepta Pharmaceuticals Polymyxin B for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Incepta Pharmaceuticals Recent Developments/Updates
  • 2.8 Taj Pharmaceuticals
    • 2.8.1 Taj Pharmaceuticals Details
    • 2.8.2 Taj Pharmaceuticals Major Business
    • 2.8.3 Taj Pharmaceuticals Polymyxin B for Injection Product and Services
    • 2.8.4 Taj Pharmaceuticals Polymyxin B for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Taj Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Polymyxin B for Injection by Manufacturer

  • 3.1 Global Polymyxin B for Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Polymyxin B for Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Polymyxin B for Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Polymyxin B for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Polymyxin B for Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Polymyxin B for Injection Manufacturer Market Share in 2025
  • 3.5 Polymyxin B for Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Polymyxin B for Injection Market: Region Footprint
    • 3.5.2 Polymyxin B for Injection Market: Company Product Type Footprint
    • 3.5.3 Polymyxin B for Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Polymyxin B for Injection Market Size by Region
    • 4.1.1 Global Polymyxin B for Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Polymyxin B for Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Polymyxin B for Injection Average Price by Region (2021-2032)
  • 4.2 North America Polymyxin B for Injection Consumption Value (2021-2032)
  • 4.3 Europe Polymyxin B for Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Polymyxin B for Injection Consumption Value (2021-2032)
  • 4.5 South America Polymyxin B for Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Polymyxin B for Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Polymyxin B for Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Polymyxin B for Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Polymyxin B for Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Polymyxin B for Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Polymyxin B for Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Polymyxin B for Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Polymyxin B for Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Polymyxin B for Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Polymyxin B for Injection Market Size by Country
    • 7.3.1 North America Polymyxin B for Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Polymyxin B for Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Polymyxin B for Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Polymyxin B for Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Polymyxin B for Injection Market Size by Country
    • 8.3.1 Europe Polymyxin B for Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Polymyxin B for Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Polymyxin B for Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Polymyxin B for Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Polymyxin B for Injection Market Size by Region
    • 9.3.1 Asia-Pacific Polymyxin B for Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Polymyxin B for Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Polymyxin B for Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Polymyxin B for Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Polymyxin B for Injection Market Size by Country
    • 10.3.1 South America Polymyxin B for Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Polymyxin B for Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Polymyxin B for Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Polymyxin B for Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Polymyxin B for Injection Market Size by Country
    • 11.3.1 Middle East & Africa Polymyxin B for Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Polymyxin B for Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Polymyxin B for Injection Market Drivers
  • 12.2 Polymyxin B for Injection Market Restraints
  • 12.3 Polymyxin B for Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Polymyxin B for Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Polymyxin B for Injection
  • 13.3 Polymyxin B for Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Polymyxin B for Injection Typical Distributors
  • 14.3 Polymyxin B for Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Polymyxin B for Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Polymyxin B for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Polymyxin B for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Polymyxin B for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Polymyxin B for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Polymyxin B for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Polymyxin B for Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Polymyxin B for Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Xellia, Fresenius Kabi, Shanghai Pharmaceuticals, Eugia, Gland Pharma, Soigner Pharma, Incepta Pharmaceuticals, Taj Pharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Polymyxin B for Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    50,000 Units
    Others
    Market segment by Application
    Hospital
    Clinics
    Other
    Major players covered
    Xellia
    Fresenius Kabi
    Shanghai Pharmaceuticals
    Eugia
    Gland Pharma
    Soigner Pharma
    Incepta Pharmaceuticals
    Taj Pharmaceuticals
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Polymyxin B for Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Polymyxin B for Injection, with price, sales quantity, revenue, and global market share of Polymyxin B for Injection from 2021 to 2026.
    Chapter 3, the Polymyxin B for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Polymyxin B for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Polymyxin B for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Polymyxin B for Injection.
    Chapter 14 and 15, to describe Polymyxin B for Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now